Chinese Co. Wants $153M Award Vacated In Vitamin C MDL

Law360, Los Angeles (April 11, 2013, 8:40 PM EDT) -- North China Pharmaceutical Group Corp. on Thursday asked a New York federal judge to vacate a recent $153 million award and dismiss multidistrict antitrust litigation alleging illegal collusion in China's vitamin C industry, claiming that only NCPG's indirectly owned subsidiary was involved in the scheme.

The jury confused NCPG with its vitamin C manufacturing unit, HeBei Welcome Pharmaceutical Co. Ltd., last month when it granted a $54.1 million award that a judge later trebled. It was the latter company and its general manager, not NCPG, that...
To view the full article, register now.